What findings of progressive skin involvement with scleroderma are clinical triggers to warrant consideration of ECP in the heterogeneous population of patients? What is the clinical trial data supporting the use of ECP in scleroderma?

What findings of progressive skin involvement with scleroderma are clinical triggers to warrant consideration of ECP in the heterogeneous population of patients? What is the clinical trial data supporting the use of ECP in scleroderma?

What findings of progressive skin involvement with scleroderma are clinical triggers to warrant consideration of ECP in the heterogeneous population of patients? What is the clinical trial data supporting the use of ECP in scleroderma?


Created by

CMEducation Resources IQ&A Extracorporeal Photopheresis Intelligence Zone | The Multi-Specialty Perspective

Presenter

Ian Odell, MD, PhD

Ian Odell, MD, PhD

Ian Odell, MD, PhD
Assistant Professor
Dermatology Director, Adult Primary Care Center
Scleroderma and Myositis Program
Yale University School of Medicine